Failure of cyprohepatdine to inhibit vasopressin-stimulated cortisol release in a patient with Cushing's disease.
A case of a 21-year-old woman with Cushing's disease due to a pituitary tumor is described. The patient was treated with cyprohepatadine for 4 weeks immediately following pituitary alpha-particle irradiation. A standard vasopressin test to measure ACTH-mediated cortisol release was performed four times: prior to pituitary irradiation, after irradiation, after 4 weeks of cyproheptadine therapy, and off cyproheptadine for 2 weeks. Cyproheptadine failed to modify vasopressin-stimulated cortisol release in the patient described. This study suggests that cyproheptadine, which has previously been shown to decrease ACTH secretion, probably acts principally at the hypothalamic, rather than at the pituitary level.
D000328:Adult; D003480:Cushing Syndrome / Q000097:blood* / Q000503:physiopathology; D003533:Cyproheptadine; D005260:Female; D006801:Humans; D006854:Hydrocortisone / Q000097:blood*; D007328:Insulin; D010902:Pituitary Gland / Q000503:physiopathology; D013997:Time Factors; D014667:Vasopressins
D007328:Insulin; D014667:Vasopressins; D003533:Cyproheptadine; D006854:Hydrocortisone